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Background: Solid pseudopapillary neoplasia (SPN) of the pancreas is an extremely rare epithelial tumor of low
malignant potential. SPN accounts for less than 1% to 2% of exocrine pancreatic tumors. The aim of this study is
to report our experience with SPN of the pancreas. It includes a summary of the current literature to provide a
reference for the management of this rare clinical entity.
Methods: A retrospective analysis was performed of all patients diagnosed and treated for SPN in our hospital over
the past 15 years (1998 to 2013). A database of the characteristics of these patients was developed, including age,
gender, tumor location and size, treatment, and histopathological and immunohistochemical features.
Results: During this time period, 255 patients with pancreatic malignancy (which does not include ampulla vateri,
distal choledocal and duodenal tumor) were admitted to our department, only 10 of whom were diagnosed as
having SPN (2.5%). Nine patients were women (90%) and one patient was a man (10%). Their median age was
38.8 years (range 18 to 71). The most common symptoms were abdominal pain and dullness. Seven patients (70%)
presented with abdominal pain or abdominal dullness and three patient (30%) were asymptomatic with the
diagnosis made by an incidental finding on routine examination. Abdominal computed tomography and/or
magnetic resonance imaging showed the typical features of solid pseudopapillary neoplasm in six (60%) of the
patients. Four patients underwent distal pancreatectomy with splenectomy, one patient underwent a total mass
excision, and one patient underwent total pancreatic resection. Two required extended distal pancreatectomy with
splenectomy. Two underwent spleen-preserving distal pancreatectomy.
Conclusions: SPN is a rare neoplasm that primarily affects young women. The prognosis is favorable even in the
presence of distant metastasis. Although surgical resection is generally curative, a close follow-up is advised in order
to diagnose a local recurrence or distant metastasis and choose the proper therapeutic option for the patient.
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Solid pseudopapillary neoplasia (SPN) of the pancreas is an
extremely rare epithelial tumor of low malignant potential.
SPN accounts for less than 1% to 2% of exocrine pancreatic
tumors [1]. Until it was defined by the World Health
Organization (WHO) in 1996 as ‘solid pseudopapillary
tumor’ of the pancreas, this tumor was described by using
various names including ‘solid cystic tumor’, ‘papillary cystic* Correspondence: dralicoskun@hotmail.com
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stated.tumor’, ‘papillary epithelial neoplasia’, ‘solid and papillary
epithelial neoplasia’, ‘papillary epithelial tumor’ and ‘Frantz’s
tumor’, ‘solid and papillary tumor’, ‘solid-cysticpapillary
epithelial neoplasm’, ‘benign or malignant papillary tumor
of the pancreas’ [2]. These tumors typically occur in young
women during the second to fourth decade of life and
are histologically characterized by cystic areas and solid
pseudopapillary arranged cells. The origin of these tumors
is still a matter of controversy.
In this study, we report our experience with SPN of
the pancreas and include a summary of the current
literature to provide a reference for the management of
this rare clinical entity.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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A retrospective analysis was carried out of all patients
diagnosed and treated for SPN in our hospital over the past
15 years (1998 to 2013). A database of the characteristics
of these patients was developed, including age, gender,
tumor location (data were derived from radiological inves-
tigations or surgical records) and size (data were derived
from radiological investigations or surgical records and
finally confirmed by pathology), treatment (data were
derived from the medical records, including the types of
surgery), and histopathological and immunohistochemical
features. Pre-operative fine needle aspiration cytology
FNAC) was performed in one patient. All the patients who
underwent resection were followed up every six months.
The investigations performed included routine blood
studies, chest X-ray, CA-19-9 level and either an ultrasound
or computed tomography (CT) scan of the abdomen.
This study was approved by the Local Institutional
Review Board of Izmir Bozyaka Education and research
hospital.
Results
During this time period, of 255 patients with pancreatic
malignancy (which does not include ampulla vateri, distal
choledocal and duodenal tumor) admitted to our depart-
ment, only 10 were diagnosed as having SPN (2.5%). Nine
patients were women (90%) and one patient was a man
(10%). The patients had a median age of 38.8 years (range
18 to 71). The most common symptoms were abdominal
pain and dullness. Seven patients (70%) presented with
abdominal pain or abdominal dullness and three patient
(30%) were asymptomatic with the diagnosis made by an
incidental finding on routine examination. Abdominal CT
and/or magnetic resonance imaging (MRI) showed the
typical features of solid pseudopapillary neoplasm in six
(60%) of the patients (Figure 1). Tumor markers (AFP,Figure 1 Magnetic resonance imaging shows that the tumor is
a well-marginated, large, encapsulated, solid and cystic mass
with areas of hemorrhagic degeneration, as revealed by high
signal intensity.CEA, CA 19–9 and CA 125) were normal preoperatively
in all patients. Usually, the tumors appeared as well-
circumscribed lesions with a mixed cystic and solid com-
ponent but were almost entirely solid or else cystic with
thick walls. In one patient the tumor was located in the
pancreatic head (10%), in four patients in the body (40%)
and in the remaining five patients in the tail (50%). Four
patients underwent distal pancreatectomy with splenec-
tomy, one patient underwent a total mass excision and one
patient underwent total pancreatic resection. Two required
extended distal pancreatectomy with splenectomy. Two
underwent spleen-preserving distal pancreatectomy. The
mean diameter of the tumor was 8 cm (range 3 to 13 cm).
Patient characteristics are summarized in Table 1.
In eight cases lymph node dissection was done in a
number between 4 and 14, whereas no dissection was
needed for two patients. No lymph node metastasis was
present in any patient. Macroscopically, there was diffuse
hemorrhage and minimal necrosis between solid and
cystic areas (Figure 2). At histopathological examination,
tumor mass separated from pancreas with a fibrous
capsula was seen. Pseudopapillary, cystic and solid growth
patterns were seen in the tumor mass. Tumor cells had an
ovally shaped, small and centrally localized nucleus and
large eosinophilic cytoplasm. Tumors consisted of pseudo-
papillary structures made of cells aligned around fine
vessels, solid areas, hemorrhagic areas and cystic areas of
different size (Figure 3). No mitosis was seen in five cases,
whereas minimal mitosis was present in two cases (2/10
per high powered field) and multiple mitosis were present
in two cases (20/10 per high powered field; case numbers
6 and 9) (Table 2). The immunohistochemistry profiles are
summarized in Table 3. Capsular invasion was present in
three cases (case numbers 2, 6 and 9), spleen invasion was
also present in case number 2. Along with capsular invasion,
mitosis, nuclear polymorphism and necrosis were also
significant in case numbers 6 and 9 at the time of diagnosis.
These two cases were considered as malignant SPN and
treated with six courses of gemcitabine + cis-platinum
chemotherapy. Multiple liver and omentum metastases
developed in case number 2 at the seventh postoperative
month; this patient died at the ninth month. Multiple liver
and omentum metastases developed in case number 9 at
the 20th postoperative month and she died at the 24th
month. The other eight cases have been followed up closely
for an average of 7.9 years (between 1 and 16 years) and no
recurrence or metastasis has been seen.
Discussion
SPN is very rare; in fact, they only constitute about
5% of cystic pancreatic tumors and about 1 to 2% of
exocrine pancreatic neoplasms [3]. They present mainly
in the second and third decades of life [4]. Our series
presented with a median age of 38.8 years, which is
Table 1 Patients characteristics
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8 Patient 9 Patient 10



























Tumor location Body Tail Head Tail Tail Body + Tail Head + Body Tail Body + Tail Tail
Size(cm) 9x7x5 13x9x6.5 13x6x5.5 6.5x5.7x3.6 4.5x3.5x3.2 12.5x11x6 4.3x3x3 4x3x2 11x7x7 3x3x2
İnvasion (−) Capsule and spleen (−) (−) (−) Capsule (−) (−) Capsule (−)
Nodal status 0/14 0/10 (−) (−) 0/6 0/14 0/4 0/7 0/11 0/5






























Figure 2 Macroscopic appearance of distal pancreatectomy +
splenectomy specimen by SPN showing the solid and cystic
component with hemorrhagic areas. SPN, solid
pseudopapillary neoplasia.
Yagcı et al. World Journal of Surgical Oncology 2013, 11:308 Page 4 of 7
http://www.wjso.com/content/11/1/308significantly older than in the literature (median age of
26 years) [5,6]. The origin of solid pseudopapillary
tumors still remains unclear. These neoplasms have been
suggested to have a ductal epithelial, neuroendocrine,
multipotent primordial cell, or even an extra-pancreatic
genital ridge angle-related cell origin [7].
The clinical presentation of the tumor is usually non-
specific. Abdominal discomfort or vague pain is the mostFigure 3 Histologic appearance of solid pseudopapillar tumors. (A) So
(B) A portion of the tumor tissue shows a collection of hyaline globules. (
in the cytoplasm. (D) CD56 shows positive cytoplasmic membranous stainicommon symptom, followed by a gradually enlarging mass
and compression signs induced by the tumor. Some
patients are completely asymptomatic, with the tumor
detected incidentally by imaging studies or routine physical
examination. Usually there is no evidence of pancreatic
insufficiency, abnormal liver function tests, cholestasis,
elevated pancreatic enzymes or an endocrine syndrome.
Tumor markers are also generally unremarkable [4,8]. In
our series, seven patients (70%) presented with abdominal
pain or abdominal dullness, three patients (30%) were
asymptomatic with the diagnosis made by an incidental
finding on routine examination and preoperative tumor
markers (AFP, CEA, CA 19–9 and CA 125) were within
normal limits in all patients.
SPN can occur in every part of the pancreas but they
are slightly more common in the tail [3]. Grossly, it
appears as a large and encapsulated mass, generally well-
demarcated from the remaining pancreas. In fact, invasion
of the adjacent organs, such as the spleen or the duodenal
wall, is rare. Depending on the tumor position (head, body
or tail of the pancreas), the differential diagnosis includes
adrenal mass, pancreatic endocrine tumor, liver cyst or
tumor, or a pseudocyst [9].
Abdominal ultrasound and CT show a well encapsulated,
complex mass with both solid and cystic components and
displacement of nearby structures. There may be calcifica-
tions at the periphery of the mass and intravenous contrast
enhancement inside the mass suggesting hemorrhagiclid pseudopapillar tumors exhibit a pseudopapillary pattern.
C) Tumor cells typically show strong immunoreactivity for vimentin
ng.
Table 2 Histopathologic features























Necrosis (−) minimal minimal (−) (−) (+) (−) (−) (+) (−)
Mitosis (−) (−) 2/10 per HPF 2/10 per HPF 2/10 per HPF 20/10 per HPF (−) (−) 20/10 per HPF (−)
Pleomorphism minimal (−) minimal minimal minimal manifest minimal (−) manifest (−)
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CT has inherent limitations in showing certain tissue
characteristics, such as hemorrhage, cystic degeneration, or
the presence of a capsule. These features may, as shown at
pathology, be suggestive of specific lesions such as SPN of
the pancreas. Therefore, MR imaging may further aid in
showing these characteristics and in the differential diagnosis
of complex cystic masses within the pancreas [11]. Despite
the technological improvements, preoperative diagnosis is
difficult because of the similarity of findings among cystic
lesions. Some studies advocate preoperative endosonography
guided fine-needle aspiration biopsy for preoperative detec-
tion of the tumor, but this may not be accepted by others
because of the uncertainty in diagnosis and the possible
tumor spread [12,13]. In our series, preoperative endosono-
graphy guided fine-needle aspiration biopsy was performed
in one out of ten patients and histology confirmed SPN.
In approximately 85% of the patients, SPN is limited
to the pancreas, while about 10% to 15% of tumors have
already metastasized at the time of presentation [14]. The
most common sites for metastasis are the liver, regional
lymph nodes, mesentery, omentum and peritoneum.
Once the diagnosis of SPN is made, surgery is the first
choice of treatment. SPN is usually surrounded by a
pseudocapsule and exhibits benign or low-grade malig-
nancy. Conservative resection with preservation of as
much pancreatic tissue as possible is the treatment of
choice. According to the location of the tumor, distalTable 3 The immunohistochemistry study
Patient 1 Patient 2 Patient 3 Patient 4 Pati
Cytokeratin Focal (+) Focal (+) Focal (+) Focal (+) Foca
CEA (−) (−) (−) (−) (−)
Vimentin (+) (+) (+) (+) (+)
Chromogranin (−) (−) (−) (−) Foca
Neuron specific
enolase
(+) (+) (+) Focal slight (+) (−)
CD10 (+) Slight (+) (+) (+) Foca
CD56 Slight (+) Slight (+) (+) (+) (−)
Synaptophysin Focal (+) Focal (+) Focal (+) (−) (+)
P53 Focal slight (+) (−) (−) (−) (−)
Kİ67 (−) (−) (−) (−) Und
Progesterone (−) (+) (+) (−) (+)
EMA Rare (+) Rare cells (+) Rare cells (+) Rare cells (+) (−)pancreatectomy with or without splenectomy, pylorous
preserving pancreatoduodenectomy, Whipple operation
or enucleation can be performed. In our series, four
patients underwent distal pancreatectomy with splenec-
tomy, one patient underwent a total mass excision and
one patient underwent total pancreatic resection. Two
required extended distal pancreatectomy with splenec-
tomy. Two underwent spleen-preserving distal pancrea-
tectomy. Many studies have demonstrated that less
aggressive surgical procedures could be preferred for the
treatment of SPN [15]. Extensive lymphatic dissection
or more radical approaches are not indicated when the
disease is localized. Local invasion and metastases are
not contraindications for resection. Portal vein resection is
advocated when there is evidence of tumor invasion. For
the metastases, surgical debulking should be performed, in
contrast to other pancreatic malignancies. Metastases can
be removed with enucleations or lobectomies and some
patients with unresectable SPN may also have a long term
survival [14]. The overall five-year survival rate of patients
with SPN is about 95% [8].
Malignant SPN, designated as a solid-pseudopapillary
carcinoma, occurs in 15% of adult patients. According
to the WHO classification system, these are: 1) solid-
pseudopapillary neoplasms with borderline malignancy
potential; and 2) solid-pseudopapillary carcinomas. Cri-
teria which distinguish potentially malignant tumors
and which are classified as ‘SP carcinoma’ are: 1)ent 5 Patient 6 Patient 7 Patient 8 Patient 9 Patient 10
l (+) (−) Focal (+) (−) (−) (−)
(−) (−) (−) (−) (−)
Focal (+) (+) (+) (+) (+)
l strong (+) (−) (−) (−) (−) (−)
(+) (+) (+) (+) (+)
l (+) (+) (+) (+) (+) (+)
(+) (+) (+) (+) (+)
Slight focal (+) Slight focal (+) (−) (−) (−)
10% (+) 5% (+) (−) 10% (+) (−)
er 1% (+) 10% (+) 3% (+) (−) 10% (+) (−)
(−) (+) (+) (−) (+)
Rare cells (+) (−) (−) (−) (−)
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of the surrounding pancreatic parenchyma. A recent study
showed that some histological features, such as extensive
necrosis, nuclear atypia, high mitotic rate, immunohisto-
chemistry findings of expression of Ki-67 and sarcomatoid
areas may be associated with aggressive behavior [16].
Adjuvant therapy is used only in a small number of
patients because of the high resectability of SPN. The
role of chemotherapy or chemoradiotherapy in the treat-
ment of SPN is also unclear. In some studies, adjuvant
chemotherapy and radiotherapy are reported in some
unresectable cases with good results [17,18]. Neoadjuvant
chemotherapy or chemoradiotherapy is also reported to
have been successful in a few cases [19-22].
In the light of previous studies, our two patients
(patients number 6 and 9) had capsular invasion besides
significant mitosis (20/10 per HPF), nuclear pleomorphism
and necrosis at the time of diagnosis and Ki-67 index was
10% (+). These two patients were accepted as having ma-
lignant SPN. They were given gemcitabine + cis-platinum
chemotherapy. Multiple liver and omentum metastases
developed in case number 2 at the seventh postoperative
month; she died at the ninth postoperative month. Mul-
tiple liver and omentum metastases developed in case
number 9 at the 20th postoperative month and she died at
the 24th postoperative month.Conclusions
SPN is a rare neoplasm that primarily affects young
women. The prognosis is favorable even in the presence of
distant metastasis. Although surgical resection is generally
curative, a close follow-up is advised in order to diagnose
a local recurrence or distant metastasis and choose the
proper therapeutic option for the patient.Abbreviations
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